Equity

Share Repurchase Program - Amount Remaining

AbbVie Share Repurchase Program - Amount Remaining decreased by 37.9% to $1.80B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 37.9%, from $2.90B to $1.80B.

Analysis

StatementBalance Sheet Statement
SectionEquity
First reportedQ3 2016
Last reportedQ1 2026May 8, 2026
Metric ID: share_repurchase_program_amount_remaining

Historical Data

15 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$2.60B$2.60B$1.40B$1.40B$1.40B$4.80B$4.80B$4.80B$3.90B$3.90B$3.90B$2.90B$2.90B$2.90B$1.80B
QoQ Change+0.0%-46.2%+0.0%+0.0%+242.9%+0.0%+0.0%-18.8%+0.0%+0.0%-25.6%+0.0%+0.0%-37.9%
YoY Change-46.2%-46.2%+242.9%+242.9%+242.9%-18.8%-18.8%-18.8%-25.6%-25.6%-25.6%-37.9%
Range$1.40B$4.80B
CAGR-10.0%
Avg YoY Growth+38.8%
Median YoY Growth-22.2%

Frequently Asked Questions

What is AbbVie's share repurchase program - amount remaining?
AbbVie (ABBV) reported share repurchase program - amount remaining of $1.80B in Q1 2026.
How has AbbVie's share repurchase program - amount remaining changed year-over-year?
AbbVie's share repurchase program - amount remaining decreased by 37.9% year-over-year, from $2.90B to $1.80B.